Oncternal Therapeutics (ONCT)
(Delayed Data from NSDQ)
$1.53 USD
-0.17 (-10.00%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.60 +0.07 (4.58%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-2.92 | 0.00% |
Earnings Summary
For their last quarter, Oncternal Therapeutics (ONCT) reported earnings of -$2.89 per share, beating the Zacks Consensus Estimate of $-3.03 per share. This reflects a positive earnings surprise of 4.62%. Look out for ONCT's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$2.92 per share, reflecting a year-over-year increase of 14.12%.
Earnings History
Price & Consensus
Zacks News for ONCT
Stevanato Group (STVN) Q2 Earnings Match Estimates
ONCT: What are Zacks experts saying now?
Zacks Private Portfolio Services